ABCL · AbCellera Biologics Inc.
$11.38
+0.41 (+3.74%)
At close · Aug 14
Market Cap
$3.49B
Shares
306.61M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding ABCL
23 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| SMALLCAP World Fund Inc | — | 13,361,096 | $46,630,225 | 0.06% | Long | 2026-03-31 | |
| iShares Biotechnology ETF | — | 1,732,022 | $6,044,757 | 0.07% | Long | 2026-03-31 | |
| BlackRock Advantage Small Cap Core Fund | — | 339,622 | $2,095,468 | 0.04% | Long | 2026-05-29 | |
| State Street(R) SPDR(R) Portfolio Developed World ex-US ETF | — | 564,888 | $1,971,459 | 0.01% | Long | 2026-03-31 | |
| iShares Genomics Immunology and Healthcare ETF | — | 411,289 | $1,706,849 | 1.06% | Long | 2026-04-30 | |
| Fidelity Nasdaq Composite Index Fund | — | 180,133 | $1,111,421 | 0.00% | Long | 2026-05-31 | |
| Driehaus Micro Cap Growth Fund | — | 249,240 | $869,848 | 0.19% | Long | 2026-03-31 | |
| Fidelity Nasdaq Composite Index ETF | — | 134,674 | $830,939 | 0.01% | Long | 2026-05-31 | |
| Adara Smaller Companies Fund | — | 120,162 | $741,400 | 0.09% | Long | 2026-05-31 | |
| State Street(R) SPDR(R) S&P(R) International Small Cap ETF | — | 164,325 | $573,494 | 0.07% | Long | 2026-03-31 | |
| Small Cap Value Fund | — | 123,712 | $431,755 | 0.07% | Long | 2026-03-31 | |
| Avantis U.S. Equity ETF | — | 64,811 | $399,884 | 0.00% | Long | 2026-05-31 | |
| Virtus Biotech Clinical Trials Etf | — | 76,245 | $316,417 | 0.85% | Long | 2026-04-30 | |
| TrueShares Technology, AI & Deep Learning ETF | BCDF | 115,391 | $257,322 | 0.92% | Long | 2025-03-31 | |
| Destinations Small-Mid Cap Equity Fund | — | 40,673 | $250,952 | 0.03% | Long | 2026-05-31 | |
| Avantis U.S. Small Cap Equity ETF | — | 39,804 | $245,591 | 0.01% | Long | 2026-05-31 | |
| Blackstone Alternative Multi-Strategy Fund | — | 66,600 | $232,434 | 0.01% | Long | 2026-03-31 | |
| Invesco RAFI Developed Markets ex-U.S. Small-Mid ETF | — | 44,281 | $183,766 | 0.05% | Long | 2026-04-30 | |
| Invesco Nasdaq Biotechnology ETF | — | 16,253 | $100,281 | 0.15% | Long | 2026-05-31 | |
| ProShares Ultra Nasdaq Biotechnology | — | 11,209 | $69,160 | 0.09% | Long | 2026-05-31 | |
| Diversified Equity Master Portfolio | — | 17,689 | $61,735 | 0.00% | Long | 2026-03-31 | |
| Apex Healthcare ETF | AESR | 2,875 | $34,011 | 0.53% | Long | 2022-10-31 | |
| Avantis U.S. Equity Fund | — | 4,396 | $27,123 | 0.00% | Long | 2026-05-31 |
Showing 1–23 of 23 positions
Key facts
CIK
1703057
CUSIP
00288U106
13F (30d)
145 filings
143 filers
Visit website
Investor relations